WeTide App WeTide focuses on nutrition and injections with smart food logging
In simple terms, semaglutide targets one hormone that makes you feel full and controls blood sugar, while tirzepatide targets two hormones that are shown to have greater improvements in metabolic health, including better insulin sensitivity and fat burning
In a 12-month study of 339 Second Nature members published in JMIR Formative Research, members taking tirzepatide (Mounjaro) lost an average of 22.1% of their body weight, and those taking semaglutide (Wegovy) lost 17.1%, in line with the averages seen in the original clinical trials
Andrew Huberman: Or the why
Acetyl-L-carnitine in diabetic neuropathy Three Class II RCTs compared ALC versus placebo in a total of 1590 patients with diabetic peripheral neuropathy
Colloids and Surfaces B: Biointerfaces,86 (1), 58-64